Raising high-density lipoprotein cholesterol with reduction of cardiovascular risk: the role of nicotinic acid – a position paper developed by the European Consensus Panel on HDL-C

By Chapman M. John   Assmann Gerd   Fruchart Jean-Charles   Shepherd James   Sirtori Cesare    

Current Medical Research and Opinion, Vol. 20, Iss. 8, 2004-08 ,pp. : 1253-1268

Informa Healthcare

Access to resources Recommend Favorite

Effectiveness of simvastatin therapy in raising HDL-C in patients with type 2 diabetes and low HDL-C

By Miller Michael   Dobs Adrian   Yuan Zhong   Battisti Wendy P.   Borisute Hannah   Palmisano Joanne  

Current Medical Research and Opinion, Vol. 20, Iss. 7, 2004-07 ,pp. : 1087-1094

Informa Healthcare

Access to resources Recommend Favorite

Association between HDL-C concentration and risk for a major cardiovascular event

By Laitinen David L.   Manthena Shivaji   Webb Silky  

Current Medical Research and Opinion, Vol. 26, Iss. 4, 2010-04 ,pp. : 933-941

Informa Healthcare

Access to resources Recommend Favorite

Investigational drugs targeting HDL-C metabolism and reverse cholesterol transport

By Robinson Jennifer G   Davidson Michael H  

Future Lipidology, Vol. 2, Iss. 3, 2007-06 ,pp. : 285-301

Future Medicine

Access to resources Recommend Favorite

Effect of L-Carnitine on the Serum Lipoproteins and HDL-C Subclasses in Hemodialysis Patients

By  

Nephron Clin Pract, Vol. 101, Iss. 4, 2005-08 ,pp. : c174-c179

Karger

Access to resources Recommend Favorite